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Background: Multi drug resistant tuberculosis(MDR-TB) is
moredifﬁcult todiagnose and treat, leading tohighmortality. Accu-
rate and rapid detection of MDR-TB is critical for timely initiation
of treatment. Evaluating new drug resistance diagnostic tools such
as Genotype MTBDRplus VER 2.0 assay offer opportunity to scale
up drug susceptibility testing(DST) capacity in Ethiopia.
Methods & Materials: A cross sectional study was conducted
from December to August, 2015 on presumptive MDR-TB patients.
Analysis of 72 smear positive and 197 smear negative sputum
samples was done with Genotype MTBDRplus VER 2.0 assay and
compared with the reference, BACTEC MGIT 960 culture and DST.
Sensitivity, speciﬁcity, PPV and NPV of the MTBDRplus VER 2.0
assay was calculated, comparing the results with the reference
method and resultswas interpreted based on 95% conﬁdence inter-
val, statistical signiﬁcant was taken at p-value <0.05.
Results: The sensitivity, speciﬁcity, PPV and NPV of Genotype
MTBDRplus VER 2.0 assay were 96.4, 100, 100 and 96.9%, respec-
tively for the detection of MDR-TB from direct smear positive
sputum samples. Only 14(54%) samples had valid results with LPA
among the26 smearnegative culturepositive samples. The remain-
ing 8(30.6%) and 4(15.4%) were invalid and negative with LPA,
respectively. The sensitivity and speciﬁcity of Genotype MTBDR-
plus VER 2.0 assay was 100% for the detection of MDR-TB among
14 direct smear negative and culture positive sputum samples.
The most common mutations associated with RMP and INH resis-
tance was S531L and S315TL, respectively. A single rare mutation
(C15T/A16G) was also detected in this study.
Conclusion: The diagnostic performance of Genotype MTBDR-
plus VER 2.0 assay in direct smear positive sputum sample was
highly sensitive and speciﬁc for early detection of MDR-TB. How-
ever, the diagnostic performance of Genotype MTBDRplus VER 2.0
assay in direct smear negative sputum samplewas low and showed
high level of invalid results so it is unlikely to implement Genotype
MTBDRplus VER 2.0 assay for the detection of MDR-TB in direct
smear negative sample in our routine settings until the method is
optimized. Hence, large scale further studies are needed in direct
smear negative samples.
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Background: Tuberculosis (TB) along with HIV infection is the
major cause of mortality worldwide including the 29 million peo-
ple in Nepal. The steady rise in the number of Multi-drug Resistant
(MDR) TB cases in the last few years has increased the challenges
facing the scientists and health professionals alike. With no pre-
vious epidemiological data available on transmission patterns of
Mycobacterium tuberculosis complex (MTBC) in Nepal, the focus
of this study is to categorise the TB samples for the ﬁrst time
using IS6110 ﬂuorescent ampliﬁed fragment length polymorphism
(FAFLP) PCR into different genetic lineages.
Methods & Materials: The bacterial DNA from clinical isolates
of 176 TB patients in Nepal along with the reference strain H37Rv
were extracted using the CTABmethod and subjected to FAFLP PCR,
using four differentially labelled selective primers. The samples
separated on the ABI Genetic Analyser 3730xl were then analysed
using the PeakScanner software and were identiﬁed using their
ﬂuorescent tag. The 4-dye FAFLP data collected from the different
proﬁles were later recorded in the BioNumerics software v6.1and
compared with the reference global collection of TB samples.
Method schematic of 4-dye IS6110 FAFLPPCR. In the example
shownabove (A), red fragment is generated as TaqI -C anneals to
the C base in the DNA where base C is ampliﬁed and in example
(B) exact insertion of IS6110 in the Mtb genome is identiﬁed
using
Results: Out of 176 samples analysed, 64 samples belong to the
Central Asian (CAS) lineage or principal genetic group 1(PGG1), 33
samples belong to the Beijing lineage (PGG1) and the rest of the
samples belong to other genetic groups – LAM, Haarlem, X (PGG2)
andT (PGG3).Also, all but twoof the sixteen insertion sitesofH37Rv
were mapped using this technique.
